Long-term Immune Responses in Patients with Confirmed Novel Coronavirus Disease-2019: a 9-Month Prospective Cohort Study in Shanghai, China

Gong Xiaohuan,Cui Peng,Wu Huanyu,Pan Hao,Teng Zheng,Yuan Fang,Mao Shenghua,Kong Dechuan,Han Ruobing,Zhao Xue,Zheng Yaxu,Xiao Wenjia,Zhu Yiyi,Fang Qiwen,Lin Sheng,Jin Bihong,Chu Ruilin,Jiang Chenyan,Yu Xiao,Qiu Qi,Lu Yihan,Wang Weibing,Fu Chen,Sun Xiaodong
DOI: https://doi.org/10.1186/s12879-022-07173-0
IF: 3.7
2022-01-01
BMC Infectious Diseases
Abstract:The duration of antibodies against SARS-CoV-2 in Covid-19 patients remains uncertain. Longitudinal serological studies are needed to prevent disease and transmission of the virus. In 2020, 414 blood samples were tested, obtained from 157 confirmed Covid-19 patients, in a prospective cohort study in Shanghai. The seropositive rate of IgM peaked at 40.5% (17/42) within 1 month after illness onset and then declined. The seropositive rate of IgG was 90.6% (58/64) after 2 months, remained above 85% from 2 to 9 months and was 90.9% (40/44) after 9 months. Generalized estimating equations models suggested that IgM (P < 0.001) but not IgG significantly decreased over time. Age ≥ 40 years (adjusted odds ratio [aOR] 4.531; 95% confidence interval [CI] 1.879–10.932), and cigarette smoking (aOR 0.344; 95% CI 0.124–0.951) were associated with IgG, and age ≥ 40 years (aOR 2.820; 95% CI 1.579–5.036) was associated with IgM. After seroconversion, over 90% and 75.1% of subjects were estimated to remain IgG-positive 220 and 254 days, respectively. Of 1420 self-reported symptoms questionnaires, only 5% reported symptoms 9 months after onset. In patients with a history of natural infection, anti-SARS-CoV-2 IgG is long-lived, being present for at least 9 months after illness onset. The long duration of natural immunity can mitigate and eliminate Covid-19 and the ongoing pandemic.
What problem does this paper attempt to address?